Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News

BD Diagnostics seeks 510(k) approval for HSV 1 and II assays; Celera submits premarket approval application for KIF6 Genotyping Assay; Cepheid launches Xpert Flu as CE IVD Marked test in Europe.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.